BIONANO GENOMICS, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • March 10th, 2023 • Bionano Genomics, Inc. • Laboratory analytical instruments • New York
Contract Type FiledMarch 10th, 2023 Company Industry JurisdictionThis DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between BIONANO GENOMICS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
BIONANO GENOMICS, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • January 19th, 2021 • Bionano Genomics, Inc • Laboratory analytical instruments • New York
Contract Type FiledJanuary 19th, 2021 Company Industry JurisdictionThis DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between BIONANO GENOMICS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
CASTLE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • December 14th, 2020 • Castle Biosciences Inc • Services-medical laboratories • New York
Contract Type FiledDecember 14th, 2020 Company Industry JurisdictionThis DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between CASTLE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
GENITOPE CORPORATION and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFDebt Securities Warrant Agreement • October 19th, 2007 • Genitope Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 19th, 2007 Company Industry JurisdictionDebt Securities Warrant Agreement (this “Agreement”), dated as of between Genitope Corporation, a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
VOLCANO CORPORATION and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFDebt Securities Warrant Agreement • September 21st, 2007 • Volcano CORP • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledSeptember 21st, 2007 Company Industry JurisdictionDebt Securities Warrant Agreement (this “Agreement”), dated as of between Volcano Corporation, a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
ONYX PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF ONYX PHARMACEUTICALS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENTDebt Securities Warrant Agreement • May 30th, 2006 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 30th, 2006 Company Industry JurisdictionDebt Securities Warrant Agreement, dated as of ___, between Onyx Pharmaceuticals, Inc., a Delaware corporation (the “COMPANY”) and ___, a [corporation] [national banking association] organized and existing under the laws of ___ and having a corporate trust office in ___, as warrant agent (the “WARRANT AGENT”).